Prestige Consumer Healthcare (PBH) Divestments (2016)

Prestige Consumer Healthcare (PBH) recorded quarterly Divestments of $48.4 million in Q4 2016.

Prestige Consumer Healthcare (PBH) Divestments (2016) Analysis & Trends

Prestige Consumer Healthcare's Divestments history runs 1 years deep, the most recent figure standing at $48.4 million for Q4 2016.

  • In Q4 2016, Divestments changed N/A year-over-year to $48.4 million; the TTM figure through Mar 2017 stood at $48.4 million (changed N/A YoY), while the FY2019 annual figure was $65.9 million, changed N/A from the prior year.
  • Divestments was $48.4 million for Q4 2016 at Prestige Consumer Healthcare.
  • In the past five years, Divestments ranged from a high of $48.4 million in Q4 2016 to a low of $48.4 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 42.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 24.21 Mn
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 48.40 Mn